Labow Brian I, Alshamekh Shomoukh A, Carlberg Valerie M, Zacur Jennifer L, Uihlein Lily C, Mulliken John B, Liang Marilyn G
From the Harvard Medical School, Boston, Mass.
Department of Plastic and Oral Surgery, Boston Children's Hospital, Boston, Mass.
Plast Reconstr Surg Glob Open. 2024 Jan 8;12(1):e5506. doi: 10.1097/GOX.0000000000005506. eCollection 2024 Jan.
The literature is meager regarding the natural history and outcomes of infantile hemangiomas (IHs) in the breast. Treatment in childhood may be considered due to psychosocial and physical concerns with breast development. Early surgical intervention may cause iatrogenic breast asymmetry and possibly impair lactation later in life. This study characterizes the clinical presentation, management, and long-term outcomes of IHs arising in the breast.
Female patients aged 11 years or older at presentation were included in a retrospective review of the Vascular Anomalies Center database for patients with IHs of the breast seen at our institution between 1980 and 2020. Breast development was ascertained by a structured telephone interview, physical examination, or photographs.
A total of 10 patients met criteria for inclusion in this study. The median age at enrollment was 14 years (11-36 years). Breast asymmetry was noted in 60% of patients (n = 6). Of the four patients who underwent subtotal excision of breast IH, three developed ipsilateral breast hypoplasia. Breast asymmetry was also noted in three of five patients who did not receive medical treatment: two with hypoplasia and one with hyperplasia. No asymmetry was noted in the single patient who received corticosteroid.
IHs involving the nipple-areola complex can be associated with breast asymmetry. Hypoplasia was noted in patients not treated with corticosteroid or resection in childhood. These findings suggest that systemic treatment should be considered. Longitudinal follow-up on patients treated with propranolol will elucidate its possible benefits in minimizing breast asymmetry.
关于乳腺婴幼儿血管瘤(IHs)的自然病史和转归的文献较少。由于心理社会因素和对乳腺发育的生理担忧,可能会考虑在儿童期进行治疗。早期手术干预可能会导致医源性乳腺不对称,并可能损害日后的哺乳功能。本研究对乳腺IHs的临床表现、治疗及长期转归进行了描述。
对1980年至2020年在本机构就诊的乳腺IHs患者的血管异常中心数据库进行回顾性研究,纳入就诊时年龄在11岁及以上的女性患者。通过结构化电话访谈、体格检查或照片确定乳腺发育情况。
共有10例患者符合本研究的纳入标准。入组时的中位年龄为14岁(11 - 36岁)。60%的患者(n = 6)存在乳腺不对称。在4例行乳腺IHs次全切除的患者中,3例出现同侧乳腺发育不全。在5例未接受治疗的患者中,也有3例存在乳腺不对称:2例发育不全,1例增生。接受皮质类固醇治疗的1例患者未出现不对称情况。
累及乳头乳晕复合体的IHs可能与乳腺不对称有关。未在儿童期接受皮质类固醇或手术治疗的患者出现了发育不全。这些发现提示应考虑进行全身治疗。对接受普萘洛尔治疗的患者进行纵向随访将阐明其在最小化乳腺不对称方面的潜在益处。